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Trapping of the transport-segment DNA by the
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Type II topoisomerases alter DNA topology to control DNA supercoiling and chromosome
segregation and are targets of clinically important anti-infective and anticancer therapeutics.
They act as ATP-operated clamps to trap a DNA helix and transport it through a transient
break in a second DNA. Here, we present the ﬁrst X-ray crystal structure solved at 2.83 Å of a
closed clamp complete with trapped T-segment DNA obtained by co-crystallizing the ATPase
domain of S. pneumoniae topoisomerase IV with a nonhydrolyzable ATP analogue and 14-mer
duplex DNA. The ATPase dimer forms a 22 Å protein hole occupied by the kinked DNA
bound asymmetrically through positively charged residues lining the hole, and whose
mutagenesis impacts the DNA decatenation, DNA relaxation and DNA-dependent ATPase
activities of topo IV. These results and a side-bound DNA-ParE structure help explain how
the T-segment DNA is captured and transported by a type II topoisomerase, and reveal a new
enzyme–DNA interface for drug discovery.
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Changes to the topological state of DNA are required formany DNA transactions including DNA replication andchromosome segregation1–3. Topoisomerases are ubiqui-
tous enzymes that act to alter DNA topology and are the targets
of clinically important antibacterial and anticancer drugs1–7.
Bacteria usually express two highly conserved type IIA topoi-
somerases (Top2As), topoisomerase (topo) IV and DNA gyrase,
involved respectively in chromosome relaxation/segregation and
DNA supercoiling (Fig. 1)8–11. Topo IV is a tetramer composed
of two subunits, ParC and ParE, that form an active E2C2 com-
plex (Fig. 1); likewise gyrase through GyrA and GyrB subunits12.
Topo2As introduce a transient 4 bp staggered break into one
DNA duplex and pass a second DNA duplex through the break
which is then resealed (Fig. 1)13,14. The transported DNA
(termed the T segment) is thought to be captured by closure of
the N gate (ATPase gate) involving adenosine triphosphate
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Fig. 1 T-segment DNA capture and transport by type IIA topoisomerases. a The proposed type II topoisomerase reaction cycle exempliﬁed by
topoisomerase IV. ParC subunits are in grey, ParE N-terminal domain is in cyan, ParE C-terminal TOPRIM domain (containing the metal binding TOPRIM
fold) is in yellow. G-gate DNA is in green and the transported T-segment DNA is in mauve. ATP bound to the ATPase domain is denoted by a red dot.
Drug-targetable domains within the type II topoisomerase complex are highlighted in subsections A, B and C with examples on the right-hand side of the
ﬁgure. b Domain organization of S. pneumoniae topoisomerase IV. The active enzyme is a ParC2ParE2 tetramer. The ATPase domain (residues 1–402) is
shown in light blue. c Orthogonal views of the ParE44 protein in complex with a captured 14-mer T-segment DNA. N-terminal ParE domains are shown in
cartoon mode in light blue and cyan, bound AMP-PNP molecules are in red and T-segment DNA is in mauve/yellow for backbone/bases, respectively
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(ATP)-dependent dimerization of the ParE/GyrB ATPase
domains allowing T-segment presentation to the cleavage core of
the enzyme, passage through the G (gate) segment DNA bound at
the DNA cleavage gate and subsequent release through the pro-
tein C gate (Fig. 1a)3–7,15,16. Antibacterial coumarins such as
novobiocin target the ATPase gate, whereas clinically important
ﬂuoroquinolones such as levoﬂoxacin interfere with DNA
resealing at the DNA cleavage gate (Fig. 1a)17–22.
The ParE and GyrB proteins exhibit the same modular design
with an N-terminal ATPase domain and a C-terminal magne-
sium-binding (TOPRIM) domain (Fig. 1b)3,12,23. Similarly, the
ParC and GyrA proteins are constructed of an N-terminal
breakage-reunion domain with winged helix fold, tower and C
gate, and a DNA-binding C-terminal domain (CTD)3,12.
Interestingly, eukaryotic Top2As are homodimers in which all
four domains are present in each subunit organized in a
ParE–ParC arrangement12. In mammalian cells, the enzyme is
expressed as distinct topo IIα and topo IIβ isoforms whose
DNA cleavage gates are inhibited by clinically important
anticancer drugs such as doxorubicin and etoposide (Fig. 1a)
24,25. It appears that prokaryotic and eukaryotic Top2As share a
similar double-strand break mechanism utilizing the sequential
operation of N (ATPase), DNA and protein C gates (Fig. 1a)3–5.
Structural and biochemical experiments employing topo II
inhibitors have been particularly informative about the DNA
cleavage gate. However, the nature of the T‑segment DNA and
how it is captured for transport by type II topoisomerases have
been longstanding questions in the ﬁeld.
In this study, we have co-crystallized the ParE ATPase domain
with short DNA duplexes in the presence of adenosine 5'-[β,γ-
imido]triphosphate Adenylyl-imidodiphosphate (AMP-PNP), a
non-hydrolysable ATP analogue that induces dimerization of
ATPase domains to close the ATPase gate. We report the ﬁrst co-
crystal structure of a topoisomerase ATPase complex with T-
segment DNA captured inside a cavity formed by the protein
dimer. The structure represents the ﬁrst visualization of this key
intermediate in the Top2A reaction pathway. In concert with
mutagenesis and biochemical analysis of strand passage and
ATPase stimulation (plus a second ParE structure involving side-
bound DNA), our work provides new perspectives on the
mechanism of DNA capture and passage by type IIA
topoisomerases.
Results
Structures of ParE-DNA complexes. To capture a closed ATPase
clamp with prospective T segment, we screened a variety of DNA
duplexes in co-crystallization trials with the Streptococcus pneu-
moniae ParE44 ATPase domain (residues 1–402) (Fig. 1b).
Crystals were obtained with ParE44 in the presence of AMP-PNP
using either a 14-mer DNA duplex, 5′-GCATATATATATGC-3′
or the 6-mer DNA duplex, 5′-GCGCGC-3′, and both X-ray
structures were solved by molecular replacement revealing two
different DNA binding modes (Table 1).
The structure of the ParE44–14-mer DNA complex (PDB
5J5Q) was solved in space group C2 at 2.83 Å (Fig. 1c, Table 1).
Table 1 Data collection and reﬁnement statistics
T-segment DNA—N-terminal ParE44 through-hole DNA bound
complex (5J5Q)
T-segment DNA—N-terminal ParE44 side-bound DNA
complex (5J5P)
Data collection
Space group C2 C2221
Cell dimensions
a, b, c (Å) 124.95, 72.74, 222.96 134.44, 136.46, 136.27
α, β, γ (°) 90.00, 91.89, 90.00 90.00, 90.00, 90.00
Resolution (Å) 60.76–2.83 (2.92–2.83)a 45.18–1.97 (2.04–1.97)a
Rsym or Rmerge 0.047 (0.466) 0.063 (0.367)
Rpim 0.054 (0.448) 0.049 (0.225)
CC1/2 0.993 (0.85) 0.999 (0.952)
I/σI 5.3 (1.5) 6.4 (1.7)
Completeness (%) 99.7 (99.8) 99.8 (99.8)
Redundancy 3.3 (3.3) 6.7 (7.0)
AU composition Two protein biological dimers of ParE44 are present per AU. Only
one of them contains interpretable electron density corresponding to
the bound DNA duplex (through-hole binding).
One biological dimer of ParE44 is present per AU. Each
biological dimer of ParE44 is bound by two DNA duplexes
(side binding).
Reﬁnement
Resolution (Å) 60.76–2.83 45.18–1.97
No. reﬂections 48,001 88,222
Rwork/Rfree 18.37%/26.30% 15.05%/17.40%
No. atoms
Protein 11,436 6045
DNA 568 480
Ligand/ion 151 94
Water – 824
B factors
Protein 77.62 27.34
DNA 224.79 68.63
Ligand/ion 84.32 19.41
Water – 40.47
R.m.s. deviations
Bond lengths (Å) 0.026 0.017
Bond angles (°) 2.330 1.211
aValues in parentheses are for highest-resolution shell
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Two ParE44 dimers were present in the asymmetric unit (AU):
one dimer had a trapped T-segment DNA duplex in its central
cylindrical hole (Fig. 1c) (with evidence of weaker hole-bound
density in the second dimer, likely washed out by the two possible
alternative binding modes of the palindromic DNA to the second
protein dimer). The structure shows unequivocally that DNA can
be captured in the closed ATPase gate per se, a key mechanistic
issue left open by earlier topoisomerase ATPase structures, all of
which lack DNA26–32.
ParE44 folds into two subdomains (Fig. 1c) as seen for the
related Escherichia coli GyrB43:26 an N-terminal proximal
domain (residues 1–227, commonly referred to as the GHKL
ATPase domain) formed of an eight-stranded β-sheet supported
by four α-helices, and a distal C‑terminal domain (residues
227–402, termed the transducer/RNAse P-like domain) compris-
ing a four-stranded β-sheet supported by three α-helices in its
core and further extended by a long C-terminal α-helix which
forms the bottom gate-closing arms in the dimer, as seen for E.
coli GyrB26. Both GHKL ATPase domains of the dimer have a
bound AMP-PNP molecule and a coordinated magnesium ion.
Residues 1–21 of each ParE44 monomer protrude towards ATP
binding cavities on the opposite monomer within the dimer and
sit like a lid above the adenine ring with the hydroxyls of Y-11
coming into close proximity with N3 of the adenine ring. On the
other side, N3 is proximal to M-83 and Y-113 of the same side
monomer. K-107 forms a salt-bridge with the β-phosphate of the
AMP-PNP and the octahedral coordination of the nucleotide-
bound Mg2+ is satisﬁed by oxygens of the three phosphates and
the oxygen of residue N-51.
The 14-mer DNA duplex penetrates through the 22 Å hole in
the protein formed by the ParE44 RNAse P-like domains (Figs. 1c
and 2) and is mainly in the B form apart from a kinked region
between basepairs 3 and 4 (i.e., between the ﬁrst two AT and TA
basepairs after the 5’-terminal GC and CG pairs). (Junctions
between G-C and A-T bps are known to be highly ﬂexible, one of
the reasons for using the 14-mer sequence in crystallization.) The
DNA experiences in total a complex and asymmetric 39.4° change
of direction (see Supplementary Fig. 1 for details). The major and
minor grooves of the duplex are oriented towards opposite
RNAse P-like domains of the ParE44 dimer and are almost
equalized in width due to kinking. The protein-interacting 6 bp
segment of the 14-mer duplex DNA, 5′-GCATAT (Fig. 2a) is
asymmetrically bounded by the RNAse P-like domains compris-
ing an upper arch formed by protein residues in the region
269–291 and by the short helices comprising residues 316–322 at
the end of the anti-parallel β-sheet which also in turn binds in the
major and minor grooves of the double helix from both sides of
the dimer (Fig. 2c). The two paired long C-terminal α-helices
(residues 372–402) at the base of the dimer form the other side of
the hole (Fig. 1c, Fig. 2b, c).
Kinking of the DNA is a feature of the hole-bound DNA
complex but is not seen in a second X-ray crystal structure for
ParE44 co-crystallized with AMP-PNP but with a 5′-GCGCGC-
3′ duplex solved at 1.97 Å (5J5P) (Fig. 3, Table 1). This second
complex revealed two DNA helices bound outside of the hole one
to each side of the ParE44 dimer. Both 6-mer helices are B form
and unkinked. Comparison of the ParE hole in the 14-mer hole-
bound and 6-mer outside-bound structures showed that hole
binding by DNA did not signiﬁcantly alter the dimensions of the
cavity (Supplementary Fig. 2) and that the side-bound DNAs
interact weakly with adjacent dimers in the crystal lattice
(Supplementary Fig. 3). Surprisingly, we detected extra electron
density located at the kink between basepairs 3 and 4 in the 14-
mer DNA helix (designated by “X” in Fig. 2a) but not in the
unkinked side-bound DNA structure (see Fig. 4 for the omit
electron density maps contoured for the full complexes, for DNA
and for AMP-PNP at its binding site). The extra density seen in
the kinked 14-mer DNA (Fig. 4b and Supplementary Fig. 4) is
consistent with the presence of an aromatic molecule. Reviewing
the chemical composition of our crystallization and crystal
freezing solutions, by exclusion, we tentatively ascribe the extra
density to a molecule of AMP-PNP that is intercalated into the
DNA (Fig. 2c, e), a feature that, to our knowledge, has not been
seen previously. Conﬁrmation will require a higher resolution
structure.
Additional information on DNA kinking in the hole-bound
ParE44-DNA structure arises from the 14-mer being palindromic
and therefore carrying the 5′-GCATAT ParE-binding site at both
ends of the molecule (Fig. 2a). The structure reveals that one
DNA end is bound in the ParE hole and is bent; the other 5′-
GCATAT DNA end is not bound to protein, protrudes into
solvent, adopts a B-form helix and is unbent (Figs. 2 and 4,
Supplementary Fig. 5). For the binding and bending to be
crystallographic artefacts, the DNA would need to be involved in
crystal contacts. Importantly, in the crystal lattice, the DNA
forms its only detectable protein contacts with the hole of the
protein dimer to which it is bound and not to crystallographically
related molecules (Supplementary Fig. 5). These results provide
strong evidence that the 5’-GCATAT sequence can adopt two
conformations—a B-form helix in solution that becomes bent
when bound inside the ParE hole.
Cavity residues are involved in DNA strand passage activity.
The ParE hole is lined with positively charged arginine and lysine
residues that potentially interact with DNA backbone phosphates
to stabilize the bound DNA (detailed in Fig. 2a). Interestingly, the
DNA is bound asymmetrically in the hole. Thus, the top strand
(asterisked in Fig. 2a, d) is bound by residues derived uniquely
from one or other RNAse P-like domain in the dimer (but not
both), in contrast to the more symmetric engagement of the
bottom DNA strand (double asterisk) by pairs of residues S268,
R396 and R400 contributed by both subunits (Fig. 2a, e). To
examine the functional aspects of these interactions, full-length
ParE proteins altered by individual isosteric mutation of the 12
cavity residues (Lysine or Arginine to Glutamine; Serine to Ala-
nine, Aspartate to Valine) were produced by site-directed muta-
genesis (Supplementary Table 1), overexpressed in soluble form
and puriﬁed to homogeneity. Reconstitution with full-length
ParC subunit produced the mutant topo IV complexes allowing
analysis of DNA strand passage (Fig. 5), DNA cleavage (Sup-
plementary Fig. 6) and ATPase activities (Figs. 6 and 7, Table 2).
Mutation of DNA binding residues K291, R321, K346 or R353
(lining the top arch of the ParE hole, Fig. 2a, d) abrogated or
greatly reduced the ATP-dependent DNA decatenation activity of
topo IV, whereas double changes in more distantly placed
residues K281/D282 and K313/E316 were without effect (Fig. 5a,
top three panels; Table 2). Interestingly, mutation of R396 and
R400 residues (from the crossed C-terminal α-helices) had
modest (twofold) inhibitory effects (Fig. 5a, bottom panel), with
wild-type activity observed for the S268A mutant. In addition, a
valine mutation of D269 (the residue that binds the DNA-
intercalating molecule) conferred hyperactivity in decatenation
(Fig. 5a, fourth panel, Table 2). Essentially the same pattern of
results was seen for DNA relaxation, a second strand passage
activity, except for the additional twofold stimulation of DNA
relaxation seen for the double change of K313 and E316) (Fig. 5b,
Table 2). An important control was that all 12 topo IV complexes
mutated in the DNA binding ParE cavity retained full ATP-
independent quinolone-promoted DNA cleavage activity (Sup-
plementary Fig. 6), indicating that the mutant ParE proteins are
properly folded and behave normally in activating ParC. Thus,
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these comprehensive mutagenesis experiments indicate that ParE
cavity residues, particularly K291, R321, R346 and R353, are
crucial to strand passage activity consistent with a role in
capturing T-segment DNA for transfer through the DNA
cleavage core.
Cavity mutations affect topo IV ATPase activity. Top2As
exhibit both intrinsic (basal) and DNA-activated ATPase activ-
ities33 but little is known about the protein and DNA sequence
requirements. We found that the basal activity of ParE proteins
was novobiocin sensitive (Supplementary Table 2) (showing it
was intrinsic to ParE) and, as also found for GyrB33–35, was not
enhanced by ParC or DNA alone, but required the addition of
both for DNA-stimulated activity. To explore the relation
between DNA binding and ATP hydrolysis, we examined the
effect of 12 ParE cavity mutations on the basal ATPase activity of
ParE and of topo IV using pBR322 DNA as substrate (repre-
sentative results are shown in Fig. 6 and summarized for all the
mutant proteins in Table 2). Wild-type topo IV exhibited a basal
ATPase activity that was stimulated some fourfold by addition of
linear or supercoiled plasmid DNA (Fig. 6, Table 2). K291Q,
R321Q, K346Q and R353A mutations reduced both the basal
ATPase activity of ParE and especially the DNA-stimulated
activity in the presence of ParC. Interestingly, the K291Q ParE
protein had 60% of the basal wild-type (wt) ATPase but addition
of DNA and ParC gave no stimulation consistent with the idea
that DNA binding inside the ParE cavity is required for DNA-
activated ATP hydrolysis (Fig. 6, Table 2). The K291Q change
completely abrogated DNA strand passage by topo IV (Fig. 5,
Table 2). Similar results were seen in a more limited study
describing a single mutation of the equivalent residue in GyrB34.
Mutations of residues S268, R396 and R400 associated with the
long cavity helices had no or little effect on basal ATPase, whereas
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Fig. 2 Molecular features of the ParE44 complex with hole-bound 14-mer DNA. a Amino acid side chains that interact with the DNA duplex are shown as
ellipses with colouring corresponding to the two subunits of the ParE dimer. Shortest distances between the DNA and the amino acid side chains are given
in Ångstroms. The 6 bp DNA section that interacts with ParE is coloured, the solvent-exposed region is not. The top and bottom DNA strands are in purple
and pink and are marked by single and double asterisks. X denotes a putative DNA intercalating AMP-PNP molecule shown throughout in red. The
potential weakly interacting amino acid K313 is greyed. b, c Front and top views of the DNA–protein interaction, with the uninvolved N-proximal GHKL ParE
region greyed out. Arrows from/to the zoom-in d, e showing the top (*) and bottom (**) DNA strand interaction sites indicate the direction of views
displayed in d, e. Residues targeted for mutagenesis are underscored
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hyperactivating mutations at D269 and K313/E316 both stimu-
lated the basal ATPase and greatly enhanced DNA activation
(Fig. 6, Table 2). The various effects of topo IV mutations on
ATPase activities closely paralleled those seen for decatenation
and relaxation (Table 2). Thus, mutations of DNA binding ParE
residues that strongly inhibited DNA decatenation and relaxation
also strongly reduced basal and/or DNA-stimulated ATPase
activity. These results indicate that DNA binding, ATP hydrolysis
and strand passage are closely coupled.
Short DNA duplexes stimulate ATPase activity. Given that the
5′-GCATATATATATGC-3′ duplex binds the ParE cavity as a
potential T segment (Fig. 1c), we examined whether this and
other duplex sequences are sufﬁcient to activate ATP hydrolysis
by topo IV. As seen for GyrB and the GyrB43 ATPase region33–
36, DNA alone did not measurably stimulate the very low basal
activity of ParE44 or ParE alone. However, by complementing
ParE with ParC, we showed for the ﬁrst time that short DNA
duplexes with alternating purine-pyrimidine sequences are able to
stimulate the ATPase of topo IV (Fig. 7). Activity required duplex
DNA: no stimulation was seen with single-stranded DNA. The
cavity-binding 5′-GC(AT)5GC-3′ duplex had the greatest effect—
a 2.8-fold ATPase stimulation (Fig. 7) which compares favourably
with an ~4-fold stimulation by the same weight of pBR322
(Table 2). Other duplexes were tested that were sequence
variations on the 14-mer. Substituting the 5′ end GC repeats with
CG, and/or substituting internal 5′ AT repeats with TA, or either
decreasing or increasing the number of AT repeats all failed to
stimulate topo IV ATPase activity (Fig. 7). Polymeric 5′ (GC)n
sequences were inactive when n= 3 (corresponding to the side-
bound hexamer (Fig. 3)), but were partially active when n= 5 or
7 as was 5′-(AT)7. The E-site DNA sequence that binds strongly
as a G segment to the topo IV DNA cleavage core did not sti-
mulate ATPase activity, although the V-site, a second strongly
cleaved sequence, was partially effective in ATPase stimulation
(Fig. 7). These results provide the ﬁrst evidence for any type II
topoisomerase that short DNA duplexes including the pro-
spective T-segment 14-mer (Fig. 2a) are able to stimulate the
ATPase activity, an observation with potentially important
mechanistic implications.
Discussion
Type IIA topoisomerases function as ATP-driven molecular
machines that mediate the capture of a transported (T segment)
DNA and its passage through a transient double-stranded DNA
break in a second DNA duplex (the G segment)1–7. This process
involves the sequential operation of a series of molecular gates,
i.e., the N, G and C gates1–7,15,16. How the enzymes engage a T-
segment DNA and how its capture by the N gate leads to strand
passage has long been a key unresolved issue. Our structure of a
d
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c
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C
Fig. 3 X-ray crystal structure of ParE44 with side-bound 5′-GCGCGC-3′ duplex DNA and AMP-PNP. a, b, c Front, side and bottom views of the complex
and d residues that interact with the DNA and were targeted for mutagenesis (underscored). The ParE44 protein forms a closed dimer with two molecules
of DNA bound as a regular B-form helix but on the outside of the protein rather than in the hole. N-terminal ParE domains are shown in cartoon mode in
light blue and cyan, bound AMP-PNP molecules are in red and DNA is in mauve/yellow for backbone/bases, respectively
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05005-x
6 NATURE COMMUNICATIONS |  (2018) 9:2579 | DOI: 10.1038/s41467-018-05005-x | www.nature.com/naturecommunications
T-segment DNA trapped in the cavity formed by dimerization of
the nucleotide-bound ParE ATPase region of S. pneumoniae topo
IV (Figs. 1 and 2) is the ﬁrst structure to visualize this transient
intermediate yielding new mechanistic insights on strand passage
by type II topoisomerases. Interestingly, the ParE ATPase region
introduces a kink into the T-segment DNA inducing a 40° bend,
and moreover binds the DNA asymmetrically in the cavity
through differential interactions with charged protein residues
lining the hole (Figs. 1 and 2 and Supplementary Fig. 1). Muta-
tion of the full set of residues that engage the T-segment DNA
affected DNA strand passage and ATPase activities demonstrat-
ing that the crystallized complex is biologically relevant (Figs. 5
and 6, Table 2).
The ParE hole engages with a 6 bp sequence 5′-GCATAT-3′
found at both ends of the palindromic 14-mer DNA duplex
(Fig. 2a). The sequence at one end is bound through the ParE hole
and is bent, the other 5′ GCATAT end reaches out into the
solvent and is an unbent B-form helix. Apart from interactions
with the ParE dimer to which it is bound, there are no other
detectable lattice interactions of the 14-mer with adjacent ParE
a
b
c
DNA bound in the hole
(5J5Q)
DNA bound on the side
(5J5P)
Y11
I16
D78
N51 N51D78
I16
Y11
Fig. 4 Comparison of hole-bound and side-bound ParE44-DNA structures. Composite omit electron density maps (2Fobs−Fcalc) were contoured around a
the entire molecular structure, b the bound DNA and c the bound AMP-PNP in the ATP binding site. Structures on the left-hand side represent the complex
with the DNA bound in the hole formed by the ParE44 dimer. Structures on the right-hand side represent the side-bound DNA complex. In a the electron
density map is contoured at 1.5 and 1.0 σ levels for protein and DNA in blue and yellow colours, respectively. In b the electron density map is contoured at
1.0 σ level and is in light blue. In c the electron density map is contoured at the 1.5 σ level only and is in blue. In a the protein and DNA are displayed in
cartoon mode in light blue/cyan and red, respectively. In b the DNA backbone is in pink with phosphates indicated by spheres, the DNA bases are in yellow
and the intercalated molecule X is in red. In c the bound AMP-PNP molecule and the coordinated magnesium are shown in yellow, while the protein
residues are in light blue/cyan. Magnesium is shown as a sphere, side chains and AMP-PNP are shown using stick representation and the protein backbone
is displayed in cartoon mode
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dimers (Supplementary Fig. 5). This “internal control” suggests
that kinking of the T-segment DNA occurs on binding to the
ParE hole. This ﬁnding opens up the prospect of separate studies
to detect T-segment bending by FRET or by gel retardation
approaches.
One interesting aspect of the structure is that the 14-mer T-
segment DNA duplex is readily accommodated by the 22 Å ParE
cavity and by solvent channels in the crystal lattice
(Supplementary Figs. 2 and 5). These features likely account for
the higher DNA temperature factors (B factors) for the hole-
bound DNA (224.79 Å2) compared to the protein (~78 Å2) and
which increase along the DNA chain from ~190 Å2 for the hole-
bound DNA end to ~260–350 Å2 for the solvent-exposed end
(Table 1). These results suggest the DNA is less ordered than the
protein consistent with loose DNA binding in the dimeric ParE
annulus (Fig. 4). By comparison, for the side-bound DNA-ParE44
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Fig. 5 Mutations of ParE cavity residues affect DNA strand passage by topo IV. Complexes of topo IV reconstituted with ParE bearing cavity mutations at
residues K291, R321, K346 or R353 exhibit greatly reduced DNA decatenation (a) and DNA relaxation (b) activities. a A representative decatenation
experiment. For each panel, kinetoplast DNA was incubated at 37 °C for 1 h in decatenation buffer (40mM Tris-HCl (pH 7.5), 6 mM MgCl2, 10mM DTT,
200mM potassium glutamate, 50 µg ml−1 BSA) with 1 mM ATP and S. pneumoniae topoisomerase IV reconstituted from a ﬁxed amount of ParC (25 ng)
(and in experiments not shown up to 2000 ng) and titrated with either wild-type or mutant ParE (as indicated) at 100, 20, 10, 5 and 2.5 ng (lanes 1–5,
respectively in each panel). Reactions were terminated and the DNA products were separated and visualized by electrophoresis in 1% agarose gels. Lane C,
no enzyme addition. kDNA, kinetoplast DNA; Mini denotes minicircle DNA released by topo IV. Intermediate bands are partially unlinked DNA species. b
Relaxation assays for topo IV were carried as described for kDNA decatenation except supercoiled plasmid pBR322 DNA (400 ng) was used as substrate
with the same level of ParC (25 ng) and wild-type or mutant ParE at 100, 40, 20, 10 and 5 ng (each panel lanes 1–5, respectively). DNA products were
analysed on 1% agarose gels. Lane C, no enzyme addition. R and S, relaxed and supercoiled DNA, respectively
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complex, the B factors on DNA and protein are 69 Å2 and 27 Å2,
indicating tighter binding of the side-bound DNA (Table 1),
possibly enhanced by DNA interactions between adjacent dimers
in the crystal (Supplementary Fig. 3). Lack of tight DNA binding
to a protein cavity is expected to be advantageous for enzymes
such as type II topoisomerases where DNA movement or trans-
port is central to catalysis. Indeed, the B factors are in line with
other structures involving protein annulus–DNA interactions
where the DNA is dynamic, for example, a proliferating cell
nuclear antigen (PCNA)–DNA complex (PDB 3K4X) and SV40-
T antigen complex (5CTC) wherein the B factors on the DNA are
in the 300 Å2 range37,38, and the Ku protein–DNA complex
(1JEY) where the B factors are in the 80–100 Å2 range39.
Mutagenesis of particular cavity residues identiﬁed from the
14-mer structure generally had parallel effects on the DNA dec-
atenation, relaxation and ATPase activities of topo IV (Table 2).
Thus, changes to residues K291, R321, K346 and R353 from the
top arch of the cavity severely compromised both DNA strand
passage and ATP hydrolysis conﬁrming key roles of these resi-
dues in T-segment capture. Much weaker inhibitory effects (≤2-
fold) were seen for mutagenesis of other residues such as S268 (no
effect), and for R396 and R400 from the long alpha-helical arms
forming the bottom of the cavity (Table 2). Hyperactivity in DNA
strand passage and especially DNA-stimulated ATP hydrolysis
was conferred for some ParE substitutions, notably by a valine
substitution of D269, a residue that contacts the putative AMP-
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Fig. 6Measuring the ATPase activity of ParE proteins. a Comparison of basal ATPase rates for wild-type (WT) and representative ParE cavity mutants and
stimulation by ParC and DNA. A coupled enzyme assay was used wherein ATPase activity was measured through the change in NADH absorbance at 340
nm34,35. The reaction mix contained topo IV decatenation buffer, 2 mM ATP and 100 nM ParE and was incubated at 37 °C in the presence or absence of
130 nM ParC and 10 µg pBR322 (ﬁnal volume of 500 µl). b Bar chart showing the ATPase activity of WT ParE and various single mutants of ParE observed
in the absence and presence of DNA and ParC (to form topo IV). Reactions were carried out in triplicate on separate days. Error bars show the standard
error. Inclusion of DNA or ParC alone did not stimulate ParE ATPase activity. The ParE D269V mutant showed strong basal ATPase activity that was
greatly enhanced by inclusion of ParC and DNA
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PNP intercalated at the DNA kink (Figs. 2 and 6, Supplementary
Fig. 4, Table 2). Such hyperactive behaviour is not easily explained
but could result from more efﬁcient capture of the T segment due
to the removal of the negatively charged protein residue from the
vicinity of the putative phosphate position of the AMP-PNP.
Another new ﬁnding is that certain short DNA duplexes,
including the hole-binding 14-mer, are sufﬁcient to stimulate the
topo IV ATPase activity whereas other duplexes, e.g., 5′-
GCGCGC, were inactive (Fig. 7). ATPase stimulation likely arises
from DNA binding to the T-segment storage cavity in the ParE
ATPase. However, given that the full topo IV holoenzyme was
used, it is also possible for some DNA duplexes that ATPase
stimulation arose allosterically by DNA binding to the ParC CTD
or to the DNA gate (although against this we note from Fig. 7 that
the strongly cleaved E-site gate-DNA did not stimulate ATPase
activity). Any binding to sites in ParC would complicate FRET
analysis. As noted earlier, it is difﬁcult to rationalise the outcomes
in Fig. 7 using DNA sequence alone or on the basis of the ParE-
14-mer structure which shows there are no direct protein contacts
with DNA bases but rather interactions with the DNA backbone
phosphates (Fig. 2a). Taken together, it is more likely that DNA
conformation, e.g., the propensity for DNA bending rather than
the DNA sequence per se, accounts for closely related DNA
duplexes having different ATPase activating effects.
It was unexpected to recover a side-bound DNA-ParE complex
in addition to that for the hole-bound bent DNA state (Figs. 1–4).
Both complexes bind DNA asymmetrically through preferential
interaction with one of the two subunits of the ParE44 dimer. The
biological role of side-bound DNA is not immediately clear.
However, importantly we note that the side binding of DNA to
ParE occurs exclusively through K291, R321, and K346 and K281,
i.e., an exact subset of the residues seen in the hole-bound DNA
complex and shown by mutagenesis of 291, 321 and 346 to be
important for enzyme activity (Figs. 2 and 3d, and Table 2). Lack
of additional crystal lattice contacts for the bent DNA and weak
crystal lattice interactions for the side-bound DNA (mainly
allosteric contacts between major grooves of the crystal-
lographically related DNA molecules) allows us to speculate that
the two complexes represent consecutive stages of T-segment
recognition and capture. We propose that binding ﬁrst occurs
through the side-bound DNA process and is crucial for initial
stabilization of the T segment (reﬂected in the higher impact of
mutation of the protein residues involved). Having bound to one
of the ParE domains in the open clamp state, capture of the T
segment occurs upon approach of the other domain and dimer-
ization promoted by ATP. Engagement with other residues in the
cavity, the possible high bendability of sequences such as 5′-
GCATAT and putative intercalation would act to stabilize the T
segment within the cavity.
The novel ParE-DNA structures (Figs. 1–3) give new per-
spective on several puzzling features of type II topoisomerase
mechanism. First, asymmetric interaction of the captured T
segment with the ParE subunits forming the ATPase hole (Fig. 2)
provides an attractive mechanism for the observed stepwise
hydrolysis of the two bound ATP molecules40,41. Secondly, the
demonstrated ability of the ATPase hole to accommodate the T
segment argues against an additional T-segment storage cavity
proposed (on the basis of a low-resolution cryo-electron micro-
scopy gyrase-DNA structure) to lie between the ATPase region
and the cleavage core42. Third, in our closed clamp ParE44-DNA
structures, the long C-terminal alpha-helices are crossed forming
the bottom of the protein hole (Figs. 1–3). This feature is seen in a
number of closed clamp topoisomerase structures but is absent in
the open clamp state, raising questions as to whether and when
twisting/untwisting of ATPase subunits takes place30,31. In the
type II topoisomerase holoenzyme, it is perhaps unlikely that the
helical arms would be crossed prior to T-segment passage as they
would need to untwist again to allow T-segment escape and
transport. Conceivably, the helical arms do not cross until after
the T segment has passed, in which case the DNA contacts seen
here with the crossed arms would be fortuitous. In support of this
view, mutations in or close to the helical arms had weak inhibi-
tory effects on topo IV DNA strand passage and DNA stimulated
ATPase activities (Fig. 5, Table 2) consistent with minimal DNA
contact with uncrossed helical arms and suggesting that ATPase
subunit twisting with concomitant long arm crossing occurs after
T-segment transit on to the cleavage core, as proposed in a recent
model by Martinez-Garcia et al.43.
Our studies on the ParE44-DNA complexes identify both
overlap and differences with other topoisomerase ATPase
domains and cognate systems. There are some similarities in fold
and some positively charged residues match in the sequence
alignment with the RNA-bound protein of Thermatoga maritima
RNAse P itself (Supplementary Fig. 7)44. However, RNAse P is
much richer in Arg and Lys residues, makes many more contacts
with the RNA and uses different residues compared with the
binding of ParE to DNA. It appears that the RNAse P-like
domain of ParE and the protein subunit of the ribonucleotide
complex of RNAse P interact very differently with their nucleic
acid partner. Sequence alignment of S. pneumoniae ParE44 with
the ATPase domains of other type II topoisomerases reveals
conservation and divergence in the residues interacting with
DNA viz strong overall conservation of ParE R400; conservation
among bacterial gyrases and topo IVs of K291, R321 and K346
but not in eukaryotic topoisomerases; and highly divergent resi-
dues corresponding to S268, D269, R353, R396 (Supplementary
Fig. 8) pointing to potential differences in T-segment binding by
eukaryotic type II enzymes. Furthermore, eukaryotic type II
topoisomerases have a 22-residue insertion loop in the GHKL
ATPase domain absent in prokaryotes (Supplementary Fig. 8)
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Fig. 7 Short DNA duplexes stimulate ATP hydrolysis by topoisomerase IV.
Using the conditions described in the legend to Fig. 6, topo IV was
incubated with 2mM ATP in the absence and presence of a variety of short
annealed oligonucleotide duplexes (10 µg) and ATP hydrolysis was followed
by a coupled assay. The results shown are the average of three independent
measurements. In the absence of DNA, the basal ATPase activity of topo IV
was 12.4 nM s−1. Asymmetric E20 and V20 are 20-mers of the E and V
sites that bind as G (gate DNA) segments and are strongly cleaved by topo
IV22,30 and were produced in duplex form by annealing complementary
strands as carried out for 5′-GC(TA)4TCG-3′
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that drops down near the ATPase hole and could potentially clash
with T-segment binding or transport (Fig. 8). Accordingly,
eukaryotic topo II may kink the T-segment DNA more severely to
allow its capture, require a conformational change of the loop or
engage the T segment differently perhaps using the loop for DNA
sequence sensing. Different to topo IV, we note that early studies
on E. coli DNA gyrase showed that ATP hydrolysis was largely
dependent on DNA length requiring a ≥70 bp DNA substrate but
did not exclude preferred DNA sequences33. Our preliminary
studies show that the 14-mer duplex effective with topo IV did
not activate the gyrase ATPase, suggesting enzyme differences for
gyrase perhaps linked to its requirement for DNA wrapping and
intramolecular strand passage13,33. This information should aid
the development of new antibacterial and anticancer agents tar-
geting prokaryotic or eukaryotic topoisomerases.
In this paper, we reveal the ﬁrst structure of a prospective T-
segment DNA bound in the cavity formed by the closed ATPase
clamp of a Top2A complex—a crucial intermediate in the
Topo2A reaction pathway—as well as the ﬁrst structure of a side-
bound DNA-ParE complex that may cast light on how Top2As
initially recognize the T segment. We show that the cavity-bound
DNA is kinked and binds asymmetrically providing a structural
rationale for the stepwise hydrolysis of the two ATP molecules.
Comprehensive mutagenesis of cavity residues reveals strong
effects on enzymatic DNA strand passage and ATP hydrolysis
demonstrating biological relevance to the reaction pathway.
Moreover, we show that short DNA duplexes activate the Top2A
ATPase in a manner dependent on DNA conformation. Overall,
we provide structural and biochemical insights that resolve a
number of outstanding conundrums of Top2A mechanism that
will stimulate new lines of experimentation and open new ave-
nues for the discovery of novel therapeutic agents.
Methods
Plasmids and DNA substrates. Plasmid pET-29a was used as a vector for over-
expression of wild-type and mutant ParE proteins in E. coli host BL21(λDE3)
pLysS. Supercoiled pBR322 was obtained from New England Biolabs. Kinetoplast
DNA (kDNA) was purchased from TOPOGEN, Inc. (Columbus, Ohio). All oli-
gonucleotides including the 14-mer palindromic DNA sequence 5′‑GCATATA-
TATATGC-3′ and 5′-GCGCGC-3′ were synthesized by solid-phase
phosphoramidite chemistry and doubly HPLC puriﬁed by Metabion, Munich.
DNA was dissolved in 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM 2-
mercaptoethanol and 0.05% sodium azide at the ﬁnal concentration of 1 mM. The
oligomers were annealed or self-annealed by heating to 95 °C and slowly cooled
over 2 nights in a Dewar ﬂask kept in the cold room at 4 °C.
Chemicals and reagents. Ciproﬂoxacin-HCl was provided by Bayer UK (New-
bury, UK). β-Nicotinamide adenine dinucleotide (reduced form, dipotassium salt),
pyruvate kinase, lactate dehydrogenase, phospho(enol)pyruvic acid monosodium
salt hydrate and AMP-PNP were from Sigma Aldrich.
Puriﬁcation of S. pneumoniae ParE44. The duplex DNA encoding the ParE
ATPase domain (UniProt Q59961, residues 1–402, plus 6xHis C-terminal tag) was
synthesized by GENEWIZ and cloned into pET28b vector between NcoI and XhoI
sites. E. coli BL21 λDE3 competent cells (Novagen) were transformed according to
the manufacturer’s protocol. The cell culture was grown in LB broth at 30 °C for
overexpression with constant agitation and induced with 1 mM isopropyl β-D-1-
Table 2 Activities of wild-type and mutant topo IV enzymes
Protein Decatenation Relaxation Cleavage Basal ParE ATPase Topo IV+DNA, fold stimulation
Wild-type ParE 100% 100% 100% 100% 4.15
*ParE K291Q No activitya No activitya 100% 57% 1.0
*ParE R321Q 20–25% 20% 100% 86% 1.6
*ParE K346Q 30% ~25% 100% 72% 1.6
*ParE R353A 10% 10% 100% 72% 1.37
*ParE R353Q 10% 10% 100% 200% 1.3
*ParE K346Q/R353A 1% <0.5% 100% 93% 1.2
*ParE K281Q/D282A 100% 100% 100% 74% 3.67
*ParE K313Q/E316Q 100% >100%b 100% 65% 8.5
ParE D269V 200% 200% 100% 270% 10
**ParE S268A 100% 100% 100% 100% 4.0
**ParE R396Q 50% 50% 100% 100% 1.7
**ParE R400Q 50% 50% 100% 100% 1.4
Topoisomerase IV was reconstituted from full-length ParC and wt or mutant full-length ParE and their activities were determined as the average of three independent measurements. Single asterisk
denotes complexes mutated in ParE residues that interact asymmetrically with the top strand of the DNA duplex (Fig. 2): double asterisk identiﬁes complexes mutated in residues that interact
symmetrically with the bottom DNA strand in Fig. 2
aNo activity detectable using up to 2 µg of ParE
bAbout twofold more active than wild type. The basal ATPase activity of wt and mutant ParE proteins was novobiocin sensitive (Supplementary Table 2)
Fig. 8 Overlap between the dimerized yeast topoisomerase II ATPase
domain (Protein Data Bank 4GFH])31 (shown in yellow) and S. pneumoniae
topoisomerase IV ATPase domain (through-hole DNA bound complex;
shown in blue). AMP-PNP molecules are shown in red, and DNA is shown
in pink/yellow for backbone/bases, respectively. The additional eukaryotic
topo II-speciﬁc loop is shown in red. The structure indicates a potential
clash between the bound DNA and the 22-amino acid long insertion loop in
the eukaryotic topoisomerase II structure (Supplementary Fig. 8)
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thiogalactopyranoside (IPTG; ﬁnal concentration) at OD600 of 0.6. Kanamycin
(50 µg ml−1) was included throughout the growth and expression period to prevent
loss of the plasmid. Bacteria were grown for 8 h and then harvested by cen-
trifugation. The cell pellet was subjected to one freeze–thaw cycle at −20 °C. After
thawing, cells were disrupted by sonication, resuspended in lysis buffer (50 mM
Tris-HCl, pH 7.5, 300 mM NaCl, 5 mM 2-mercaptoethanol, 50 mM imidazole,
0.05% sodium azide) and incubated on ice for 30 min. Lysozyme and ROCHE
EDTA-free protease inhibitor tablets were added to the lysis buffer to give the
recommended inhibitor concentrations. All the following puriﬁcation steps were
performed on ice or at 4 °C. Lysate was centrifuged in a Beckman Coulter JA-20
rotor at 18,000 rpm for 1 h. The pellet was discarded and the supernatant was
loaded on to a freshly packed Ni-NTA column. The column was washed ﬁrst with
the lysis buffer (minus lysozyme) and then with the wash buffer (50 mM Tris-HCl,
pH 7.5, 300 mM NaCl, 5 mM 2-mercaptoethanol, 80 mM imidazole, 0.05% sodium
azide) until no protein could be detected in the ﬂow-through (monitored using
Bio-Rad solution). Elution was performed using the elution buffer (50 mM Tris-
HCl, pH 7.5, 300 mM NaCl, 5 mM 2-mercaptoethanol, 200 mM imidazole, 0.05%
sodium azide). The eluted protein was dialyzed overnight against 20 mM Tris-HCl,
pH 7.5, 200 mM NaCl, 1 mM 2-mercaptoethanol and 0.05% sodium azide. Protein
was measured using a NanoDrop spectrophotometer and the protein was con-
centrated up to 10 mgml−1 using PEG 35,000 and Millipore dialysis tubing
(10 kDa cut-off). The protein was further dialyzed overnight against 20 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM 2-mercaptoethanol and 0.05% sodium
azide.
Crystallization. The ParE44 protein was mixed with DNA in a 1:2.2 molar ratio
and supplemented with 10 mM MgCl2. AMP-PNP was added to a ﬁnal con-
centration of 2 mM and the mixture was allowed to incubate overnight. The
crystallization mixture was then centrifuged at 10,000 rpm in a bench microfuge.
Protein–DNA complex was crystallized by the sitting drop method using MRC-2
Wilden crystallization plates and a Mosquito® robot from TTP Labtech (www.
ttplabtech.com) to set the drops. Drops were formed by mixing 600 nl of the
protein mixture and 400 nl of precipitant solution N31 (though-hole DNA bound
complex) or N47 (side-bound DNA complex) from the Natrix screen (50 mM
HEPES, pH 7.0, 5 mMMgCl2, 25% PEG MME 550 and 50 mM Tris-Cl, pH 8.5, 0.1
M KCl, 10 mM MgCl2, 30% PEG 400, respectively) from Hampton Research. Large
crystals grew over a week. Crystals were harvested, transferred to the cryoprotec-
tant (mother liquor +20–25% glycerol), monitored and adjusted using quick dif-
fraction tests on an in-house X-ray source and then immediately mounted on
Hampton pins and frozen in liquid nitrogen.
Data collection and processing. Data collection was performed at the Diamond
Synchrotron (Oxfordshire, UK), beamlines I02 (side‑bound DNA complex) and
I04 (through-hole DNA bound complex). A total of 900 images were collected with
0.2° oscillation and exposure of 0.2 s at 100% transmission. Detector–Pilatus 6MF,
wavelength was set to 0.91915 Å and 0.97949 Å, respectively. The data were
automatically processed by Xia2/SCALA45,46. The space groups were established to
be C2221 and C2 with cell dimensions being: a= 134.44 Å, b= 136.46 Å, c=
136.27 Å and a= 124.95 Å, b= 72.74 Å, c= 222.96 Å, respectively (see Table 1).
Structure solution and reﬁnement. The starting model for the ParE ATPase
domain was generated using the Phyre247 online server and E. coli gyrase B
structure48 (1EI1) as a prototype. The structure of the hole-bound 14-mer-ParE44
complex was solved by molecular replacement using Phaser49 in CCP450.
For the side-bound DNA complex, one biological dimer was found in the
asymmetric unit, while the through-hole DNA-bound complex revealed two. The
protein model was reﬁned using phenix.reﬁne51 with several rounds of manual
correction in WinCoot52. The high-resolution structure of the side-bound DNA
complex was used as a starting protein model for the through-hole-bound DNA
complex with the side-bound DNA removed. For the through-hole DNA-bound
complex, DNA density was clearly observed for one of the dimers, but not for the
other. For the side-bound DNA complex, DNA molecules were clearly seen on
both sides of the dimer. Our crystal lattice analysis indicated that the two dimers in
the AU of the through-hole protein–DNA complex are located in different
crystallographic environments, i.e., crystal lattice contacts would allow for one
dimer to have both orientations of the through-hole-bound DNA (due to the
twofold symmetry of the protein dimer), while in the case of the other dimer only
one orientation of DNA could be accommodated without a clash with
crystallographic symmetry-related molecules. The former dimer yielded no
interpretable DNA density possibly due to a mixed population of the two
orientations present, while the second dimer had a clear DNA density with its ends
extending into the open solvent cavities of the crystal and forming no noticeable
contacts with the neighbouring molecules. AMP-PNP molecules and the DNA
model were manually added/built in with WinCoot52 according to the 2Fobs−Fcalc
and Fobs−Fcalc maps and the structures were further reﬁned using phenix.reﬁne51
and several rounds of manual correction in WinCoot. Despite the restraints
implemented, the ﬁnal model for the through-hole complex exhibited somewhat
lesser geometric quality compared to the high-resolution side-bound DNA
complex (see Table 1). This can be explained by the lower resolution and more
mobile regions with poorer electron density in the molecule, particularly in the
region of the transiently bound DNA and in the regions of the solvent-exposed
exterior loops. Ramachandran statistics for the hole-bound complex showed 86%
of residues falling into favoured regions, 11% into allowed and 3% into outlier
regions respectively with the clash score of 28. For the side-bound complex the
percentages are of 97, 2 and 0.5% respectively for favoured, allowed and outlier
regions with the clash score of 4.
Model quality was assessed using WinCoot (including geometry analysis and
Ramachandran plot) as well as the veriﬁcation tools provided by the Protein Data
Bank. Figures for the paper were generated using PyMOL53, ChemDraw54 and
CorelDraw (www.coreldraw.com).
Expression of wild-type and mutant ParE and ParC proteins. Streptococcus
pneumoniae ParE and ParC subunits were expressed from plasmids pXP13 and
pXP14 that had been transformed into E. coli strain BL21(λDE3)pLysS and the
recombinant proteins were puriﬁed to >95% homogeneity using a modiﬁcation of
published protocols55–57. Cultures were grown initially at 30 °C for around 3 h
until the OD600 reached 0.3–0.4, and then shifted to 16 °C. Cultures were induced
with 0.4 mM IPTG for 17 h. Cells were harvested, processed and the soluble ParE
and ParC proteins were puriﬁed by nickel chelate chromatography55–57.
To generate ParE proteins with deﬁned mutations in the ATPase region, the
full-length parE gene in expression plasmid pXP13 was used as a template for site-
directed mutagenesis using the QuikChange protocol and oligonucleotide pairs
(39-mer to 47-mer) containing designed mutations (see Supplementary Table 1).
All procedures were carried out according to the manufacturer’s instructions.
Plasmids were recovered and sequenced to conﬁrm the appropriate mutation had
been successfully introduced. The mutant parE plasmids were then transformed
into E. coli BL21(λDE3)pLysS. Induction and puriﬁcation of soluble mutant-
and wild-type-ParE proteins to >95% homogeneity by nickel chelate
chromatography were carried out in parallel under identical conditions as
described above55–57.
Titration of ParE decatenation/relaxation activities. For decatenation of kDNA,
the standard reaction mixture (20 µl) contained 40 mM Tris-HCl (pH 7.5), 6 mM
MgCl2, 10 mM dithiothreitol (DTT), 200 mM potassium glutamate, 1 mM ATP, 50
µg ml−1 bovine serum albumin (BSA) and 400 ng of kDNA as substrate. A ﬁxed
amount of ParC subunit (25 ng) was combined with various amounts of ParE
proteins. Reaction mixtures were incubated at 37 °C for 1 h, the reactions were
terminated by addition of dye mix, and then the products were analysed by elec-
trophoresis in 1% agarose.
Relaxation assays were carried out by a similar protocol except supercoiled
plasmid pBR322 (400 ng) was used as substrate. Reaction mixes were incubated at
37 °C for 1 h, and the DNA products were examined by electrophoresis in 1%
agarose gels.
DNA cleavage assays. Reactions were set up using supercoiled pBR322 DNA
(400 ng) as substrate. Topo IV reconstituted by combining ParC (450 ng) and
either wt or mutant ParE (1 µg) was incubated with DNA in the absence or pre-
sence of ciproﬂoxacin at increasing concentrations. The reaction buffer was the
same as for decatenation except ATP was omitted. Samples were incubated at 37 °C
for 1 h followed by addition and mixing of 2 µl of 10% SDS to release cleaved DNA,
and following addition of proteinase K to 200 µg ml−1, incubation was continued at
42 °C for 1 h to remove DNA-bound proteins. Sample loading dye (5 µl) was added
to each tube. Cleavage products were separated and visualized by electrophoresis in
1% agarose.
ATPase assays. ATP hydrolysis by wt and mutant topo IV complexes (130 nM
ParC and 100 nM ParE) was carried out using supercoiled (or linear) pBR322 or
deﬁned oligonucleotide duplexes (10 µg) in decatenation buffer containing 2 mM
ATP at 37 °C (ﬁnal volume of 500 µl) using a standard assay34,35.
Data availability. Coordinates have been deposited with the Protein Data Bank
under accession numbers 5J5P and 5J5Q.
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